SPAC Valuence Merger Corp. Files for $200M IPO
SPAC Valuence Merger Corp. Files for $200M IPO
By Stephen Nakrosis
作者：斯蒂芬·纳克西
Blank-check company Valuence Merger Corp. I filed for a $200 million initial public offering on Wednesday.
空白支票公司Valuence Merger Corp.周三提交了2亿美元的首次公开募股(IPO)申请。
The company said it would concentrate on identifying a potential business combination partner "developing breakthrough technology in life sciences and/or advancing a platform for sustainable technology."
该公司表示，将专注于寻找潜在的业务合并合作伙伴，“开发生命科学领域的突破性技术和/或推进可持续技术的平台。”
It also said, "we will not pursue or consummate our initial business combination with any entity with its principal business operations in China, Hong Kong or Macau.
它还表示，“我们不会追求或完善我们与任何主要业务在中国大陆、香港或澳门的实体的初步业务合并。
Valuence Merger Corp. I said its sponsor, Valuence Capital LLC, is affiliated with investment fund Valuence Partners LP.
Valuence Merge Corp.说，其赞助商Valuence Capital LLC隶属于投资基金Valuence Partners LP。
The company said director nominee Dr. Joong Myung Cho is founder, chairman and chief executive of CrystalGenomics Inc., and Sung Yoon Woo, its CEO and director, is founder and CEO of Credian Partners Inc.
该公司说，董事提名人选赵钟明博士是CrystalGenology Inc.的创始人、董事长兼首席执行长，首席执行长兼董事首席执行长宋润宇(Sung Yoon Woo)是Credian Partners Inc.的创始人兼首席执行长。
Valuence Merger Corp. I said it applied to list its units on the Nasdaq Global Market under the symbol VMCAU.
Valuence Merge Corp.说，它申请将旗下子公司在纳斯达克全球市场上市，代码为VMCAU。
SVB Leerink is listed as the offering's sole book-running manager and Baird is listed as lead manager.
SVB Leerink被列为此次发行的唯一簿记管理人，Baird被列为牵头管理人。
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
写信给斯蒂芬·纳克希尔斯，电子邮件：stehen.naksim@wsj.com